SCHEMBL9128571

SCHEMBL9128571

C=C1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(C)O)[C@@]2(C)CCC(=O)C=C12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHBG P04278 4/20 0.65
▸ NR3C1 P04150 4/20 0.65
▸ ALDH1A1 P00352 3/20 0.65
▸ PGR P06401 3/20 0.65
▸ HTR2B P41595 2/20 0.65
▸ ADRA1A P35348 1/20 0.65
▸ CYP17A1 P05093 1/20 0.56
▸ CYP19A1 P11511 5/20 0.52
▸ GUSB P08236 1/20 0.50
▸ LMNA P02545 3/20 0.48
▸ HTT P42858 1/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ SERPINA6 P08185 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ MAPK3 P27361 1/20 0.48
▸ BLM P54132 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9128581 1.00 SHBG (0.65) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL13965592 0.86 LMNA (0.67) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL572198 0.86 LMNA (0.67) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL11240496 0.85 LMNA (0.68) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL11240498 0.85 LMNA (0.68) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL295690 0.85 LMNA (0.51) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL6693993 0.84 LMNA (0.53) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL6693991 0.84 LMNA (0.53) SHBGNR3C1ALDH1A1PGRHTR2B
Benorterone SCHEMBL635671 0.84 SHBG (0.81) SHBGNR3C1ALDH1A1PGRHTR2B
SCHEMBL11647496 0.83 CYP17A1 (0.48) SHBGNR3C1ALDH1A1PGRHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5389624-A Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids SCHERING AKTIENGESELLSCHAFT (DE) 1995-02-14 — — US disclosed
US-5236912-A Treating prostate hyperplasia and carcinoma SCHERING AKTIENGESELLSCHAFT (DE) 1993-08-17 — — US disclosed
WO-1993013122-A1 3-METHYLSULPHONYLHYDRAZONO AND 3-OXYIMINO STEROIDS, A METHOD OF PREPARING THEM, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-07-08 — — WO disclosed
EP-0538312-A1 Anti-androgenic [3,2-d]triazole steroids SCHERING AKTIENGESELLSCHAFT (DE) 1993-04-28 — — EP disclosed
WO-1992000992-A1 ANTI-ANDROGENIC [3,2-c]PYRAZOLE AND [3,2-d]TRIAZOLE STEROIDS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1992-01-23 — — WO disclosed
US-4322349-A Process for preparing 6-methylene steroids SCHERING AKTIENGESELLSCHAFT (DE) 1982-03-30 — — US disclosed
Send feedback